Used in pharmaceutical synthesis as a key intermediate in the production of protease inhibitors, particularly in the development of antiviral agents. Its complex structure allows for selective binding in enzyme active sites, making it valuable in drug design for diseases such as hepatitis C and HIV. The compound's functional groups enable further chemical modifications, facilitating the optimization of pharmacokinetic properties like bioavailability and metabolic stability. Commonly employed in research settings for structure-activity relationship (SAR) studies to enhance drug potency and reduce side effects.